Welcome to our dedicated page for Delek US Holdings SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Delek US Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Delek US Holdings's regulatory disclosures and financial reporting.
Delek US Holdings EVP and General Counsel Denise Clark McWatters reported a tax-related share disposition tied to equity compensation. On this Form 4, 3,496 shares of common stock were withheld at $48.01 per share to cover taxes upon vesting of equity awards. After this withholding, she directly owns 70,700 shares of Delek US common stock, reflecting a routine compensation and tax-settlement event rather than an open-market trade.
Sullivan Gary M Jr. reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Gary M. Sullivan Jr. received an award of 3,436 shares of common stock on June 10, 2026 at a price of $48.01 per share. After this grant and an adjustment, he beneficially owns 59,692 shares directly.
A footnote explains that his beneficially owned shares were increased by 500 shares to correct an inadvertent administrative error, indicating a bookkeeping correction rather than an additional market transaction.
Schwartzstein Christine Benson reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Christine Benson Schwartzstein received a grant of 3,436 shares of common stock on June 10, 2026, valued at $48.01 per share. This was an equity award rather than an open-market purchase. After the grant, she directly owns 18,613 shares of Delek US common stock.
Delek US Holdings, Inc. director Ezra Uzi Yemin reported a compensation-related stock grant. He received 3,436 shares of common stock on June 10, 2026 at $48.01 per share, classified as a grant or award rather than an open-market purchase.
Following this grant, Yemin directly owns 213,717 common shares. He also has an indirect position of 447,795 common shares held through Yemin Investments, LP. The filing shows an acquisition of shares, not a sale or disposition.
Moreno Leonardo reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Leonardo Moreno received an award of 3,436 shares of Common Stock. The shares were valued at $48.01 per share on the transaction date. After this grant, Moreno directly holds a total of 26,434 Delek US Holdings common shares.
Tolson Laurie Z. reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings, Inc. director Laurie Z. Tolson received a grant of 3,436 shares of common stock on June 10, 2026. The grant is recorded at a reference price of $48.01 per share and brings her direct holdings to 21,662 shares. This is a compensation-related share award rather than an open-market purchase.
Zohar Shlomo reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings, Inc. director Zohar Shlomo received a grant of 3,436 shares of common stock, recorded at a price of $48.01 per share. This was a compensation-related award, not an open-market purchase. Following the grant, Shlomo directly holds 10,082 common shares.
Delek US Holdings director Richard J. Marcogliese received a grant of 3,436 shares of common stock. The award was recorded at $48.01 per share and is classified as a grant or other acquisition, not an open-market purchase. Following this compensation-related transaction, he directly holds 55,763 common shares.
Delek US Holdings EVP Reuven Spiegel reported a routine tax-withholding transaction related to equity compensation. On the vesting of equity awards, 1,937 shares of common stock were withheld to cover taxes at a value of $48.01 per share. After this non-market disposition, Spiegel directly holds 46,435 shares of Delek US common stock.
Delek US Holdings EVP Robert G. Wright reported a routine tax-related share disposition. On the vesting of equity awards, 1,024 shares of common stock were withheld to cover tax obligations at an indicated value of $46.55 per share. After this withholding, Wright directly holds 47,124 shares of Delek US common stock, and the filing shows no open-market purchases or sales.